Cargando…
Hepatitis C virus : epidemiology, pathogenesis & treatment /
| Clasificación: | Libro Electrónico |
|---|---|
| Otros Autores: | , |
| Formato: | Electrónico eBook |
| Idioma: | Inglés |
| Publicado: |
Hauppauge, N.Y. :
Nova Science,
2012.
|
| Temas: | |
| Acceso en línea: | Texto completo |
Tabla de Contenidos:
- HEPATITIS C VIRUS:EPIDEMIOLOGY, PATHOGENESISAND TREATMENT; VIROLOGY RESEARCH PROGRESS; HEPATOLOGY RESEARCHAND CLINICAL DEVELOPMENTS; HEPATITIS C VIRUS:EPIDEMIOLOGY, PATHOGENESISAND TREATMENT; Library of Congress Cataloging-in-Publication Data; Contents; Preface; CHAPTER 1. Management of Hepatitis C VirusInfection in the Genomic Era; ABSTRACT; ABBREVIATIONS; INTRODUCTION; APPROACHES TO INVESTIGATE HOST GENETICVARIATIONS; HOST GENETIC VARIATIONS AND HCV INFECTIONWITH CANDIDATE GENE APPROACH; GENOME-WIDE ASSOCIATION STUDIES IN HCVINFECTION.
- IMPACT OF GWAS FINDINGS ON INTERFERONBASEDTHERAPY OF CHCIMPACT OF GWAS FINDINGSON NOVEL ANTI-HCV AGENTS; CONCLUSIONS; DISCLOSURE OF CONFLICT OF INTEREST; ACKNOWLEDGMENTS; REFERENCES; CHAPTER 2. Hepatic and Blood Dendritic CellSubsets in Patients with ChronicHepatitis C Virus Infection; ABSTRACT; HEPATITIS C VIRUS; DENDRITIC CELL SUBSETS; DENDRITIC CELLS IN HCV-INFECTED BLOOD; DENDRITIC CELLS IN THE LIVER; FUTURE DIRECTION ; CONCLUSION; BIBLIOGRAPHY; CHAPTER 3. Bone Metabolism Disordersin Chronic Hepatitis C VirusInfection; ABSTRACT; ABBREVIATIONS; 1. INTRODUCTION.
- 2. EPIDEMIOLOGY. CHRONIC LIVER DISEASEAND PREVALENCE OF HEPATIC OSTEODYSTROPHY. PREVALENCE OF HEPATIC OSTEODYSTROPHYIN CHRONIC HEPATITIS C3. PATHOPHYSIOLOGY: PATHOGENIC MECHANISMSINVOLVED IN BONE MASS LOSSIN CHRONIC HEPATITIS C INFECTION; Calcium and Vitamin D Disorders; Insulin-like Growth Factor 1 Deficiency (IGF-1) Deficiency; Receptor Activator of Nuclear Factor Kappa B Ligand (RANKL)and Osteoprotegerin (OPG); Hypogonadism; Hyperbilirubinemia; Genetic Factors; Lifestyle Factors; DIAGNOSIS OF HEPATIC OSTEODYSTROPHYIN CHRONIC HEPATITIS C.
- THERAPEUTIC MANAGEMENT OF HEPATICOSTEODYSTROPHY IN CHRONIC HEPATITIS CGeneral Measures. Vitamin D and Calcium Supplementation; Anti-osteoporotic Drugs in the Treatment of HepaticOsteodystrophy; Antiviral Drugs and their Effect on BMD; Orthotopic Liver Transplantation and Bone Mineral Density inChronic Hepatitis C; CONCLUSIONS; REFERENCES; CHAPTER 4. SOCS1 Involvement in LiverDamage during Hepatitis C VirusInfection; ABSTRACT; INTRODUCTION; THE SOCS FAMILY; STRUCTURE; SOCS1; THE BIOLOGICAL FUNCTION OF SOCS1; SOCS1 EXPRESSION DURING HEPATITIS CVIRUS INFECTION; ROLE OF SOCS1 IN LIVER STEATOSIS.
- INACTIVATION OF SOCS1AND INDUCTION OF FIBROSISROLE OF SOCS1IN THE CONTROL OF CARCINOGENESIS; SOCS1 SILENCING AND HCC; CONCLUSION; ACKNOWLEDGMENTS; REFERENCES; CHAPTER 5. Asymptomatic Low-LevelHepatitis C Virus Persistence; ABSTRACT; INTRODUCTION; HCV INFECTION OF THE LYMPHATIC SYSTEM; ASYMPTOMATIC LOW-LEVEL HCV PERSISTENCE; Occult HCV Infection Following Clinical Resolutionof Hepatitis C; Occult HCV Infection with Undefined Etiology; OCCULT HCV INFECTION IS NOT UNIVERSALLYDETECTED: BRIDGING THE GAPS; CLINICAL RELEVANCE OF OCCULT HCVINFECTION: TO BE OR NOT TO BE?; CONCLUSION; REFERENCES.